TWO SIGMA ADVISERS, LP - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 70 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$50,261
-43.9%
64,437
-33.5%
0.00%
Q2 2023$89,667
+142.0%
96,937
+185.1%
0.00%
Q1 2023$37,060
-16.2%
34,000
+12.2%
0.00%
Q4 2022$44,238
+34.1%
30,300
-2.6%
0.00%
Q3 2022$33,000
-45.0%
31,100
-11.9%
0.00%
Q2 2022$60,000
-72.2%
35,300
-66.4%
0.00%
-100.0%
Q1 2022$216,000105,0000.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,054,864$8,597,0005.88%
NEA Management Company, LLC 9,880,999$80,530,0004.18%
Abingworth LLP 250,000$2,033,0002.13%
New Leaf Venture Partners, L.L.C. 127,041$1,035,0000.89%
Iguana Healthcare Management, LLC 200,000$1,630,0000.66%
Rock Springs Capital Management LP 765,001$6,235,0000.46%
QVT Financial LP 783,645$6,387,0000.44%
Opaleye Management Inc. 40,000$326,0000.22%
Rathbones Group PLC 450,525$3,672,0000.20%
Virtus ETF Advisers LLC 26,974$220,0000.16%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders